AR069156A1 - Metodos para co-cultivar celulas derivadas del cordon umbilical con celulas madre menstruales - Google Patents

Metodos para co-cultivar celulas derivadas del cordon umbilical con celulas madre menstruales

Info

Publication number
AR069156A1
AR069156A1 ARP080104795A ARP080104795A AR069156A1 AR 069156 A1 AR069156 A1 AR 069156A1 AR P080104795 A ARP080104795 A AR P080104795A AR P080104795 A ARP080104795 A AR P080104795A AR 069156 A1 AR069156 A1 AR 069156A1
Authority
AR
Argentina
Prior art keywords
cells
cord blood
methods
umbilical cord
blood cells
Prior art date
Application number
ARP080104795A
Other languages
English (en)
Inventor
Julie G Allickson
Mercedes A Walton
Original Assignee
Cryo Cell Internat Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40591376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR069156(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cryo Cell Internat Inc filed Critical Cryo Cell Internat Inc
Publication of AR069156A1 publication Critical patent/AR069156A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1352Mesenchymal stem cells
    • C12N2502/137Blood-borne mesenchymal stem cells, e.g. Msc from umbilical cord blood
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1352Mesenchymal stem cells
    • C12N2502/1388Mesenchymal stem cells from other natural sources
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/24Genital tract cells, non-germinal cells from gonads
    • C12N2502/243Cells of the female genital tract, non-germinal ovarian cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se proveen métodos para obtener células expandidas de sangre de cordon umbilical humano que expresan CD34. Los métodos incluyen sembrar una cantidad suficiente de células de sangre de cordon con una cantidad suficiente de células menstruales, en condiciones de co-cultivo adecuadas para promover la expansion de las células de sangre de cordon, y co-cultivar las células de sangre de cordon con las células menstruales en condiciones de cultivo que soporten, al menos, dos o más duplicaciones de poblacion de células de sangre de cordon. También se proveen métodos para desarrollar células expandidas de sangre de cordon umbilical humano para originar cualquiera de las unidades formadoras de colonias: unidad formadora de colonia granulocítica y macrofágica (CFU-GM, por sus siglas en inglés), unidades formadoras de brotes eritroides (BFU-E, por sus siglas en inglés), y unidad formadora de colonia granulocítica, eritroide, macrofágica, megacariocítica (CFU-GEMM, por sus siglas en inglés), células precursoras de linaje sanguíneo. Las células expandidas pueden expresar CD34, SSEA-4, y HLA-II. También se proveen las composiciones de las células expandidas.
ARP080104795A 2007-10-31 2008-10-31 Metodos para co-cultivar celulas derivadas del cordon umbilical con celulas madre menstruales AR069156A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US145607P 2007-10-31 2007-10-31

Publications (1)

Publication Number Publication Date
AR069156A1 true AR069156A1 (es) 2009-12-30

Family

ID=40591376

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080104795A AR069156A1 (es) 2007-10-31 2008-10-31 Metodos para co-cultivar celulas derivadas del cordon umbilical con celulas madre menstruales

Country Status (18)

Country Link
US (2) US20090191628A1 (es)
EP (1) EP2212418A4 (es)
JP (1) JP2011501960A (es)
KR (1) KR20100091192A (es)
CN (1) CN101952416A (es)
AR (1) AR069156A1 (es)
AU (1) AU2008319284A1 (es)
BR (1) BRPI0818152A2 (es)
CA (1) CA2714777A1 (es)
CL (1) CL2008003282A1 (es)
CR (1) CR11409A (es)
EC (1) ECSP10010189A (es)
IL (1) IL205470A0 (es)
MX (1) MX2010004914A (es)
NI (1) NI201000077A (es)
PA (1) PA8802801A1 (es)
TW (1) TW200936148A (es)
WO (1) WO2009058365A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010056988A2 (en) 2008-11-13 2010-05-20 University Of South Florida Methods of treating stroke using stem cell-like menstrual blood cells
DE102011101054A1 (de) 2011-05-09 2012-02-16 Bernhard Hildebrandt Geräte und Vorrichtungen für das Implantationsverfahren für Endoprothesen, welches ein Systemzentrum und eine Systemachse sowie den dazu erforderlichen Gerätekomplex aus Fixiervorrichtung, Extensionsvorrichtung, Gliedmaßenhalterung und Steuergerät als Grundlage hat.
WO2013025189A1 (en) * 2011-08-12 2013-02-21 Cryo-Cell International, Inc. Methods for co-culturing cord blood cells or cord tissue cells with menstrual multipotent cells
KR101348093B1 (ko) * 2012-02-15 2014-01-16 고려대학교 산학협력단 공동 배양된 세포를 포함하는 섬유 및 그 제조방법
WO2014135924A1 (en) * 2013-03-08 2014-09-12 Cells For Cells Menstrual stems cells for the efficient support and expansion of cd34+ cd133+ hematopoietic stem cells in vitro
JP6754459B2 (ja) * 2013-08-19 2020-09-09 国立研究開発法人国立循環器病研究センター 羊膜間葉系細胞組成物の製造方法及び凍結保存方法、並びに治療剤
JP6512759B2 (ja) 2013-08-19 2019-05-15 国立研究開発法人国立循環器病研究センター 羊膜間葉系細胞組成物の製造方法及び凍結保存方法、並びに治療剤
WO2015066076A1 (en) 2013-10-28 2015-05-07 Biocardia, Inc. Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5840580A (en) * 1990-05-01 1998-11-24 Becton Dickinson And Company Phenotypic characterization of the hematopoietic stem cell
US7410773B2 (en) * 1995-02-02 2008-08-12 Ghazi Jaswinder Dhoot Method of preparing an undifferentiated cell
US7560280B2 (en) * 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
WO2006078034A1 (ja) * 2005-01-24 2006-07-27 Japan Health Sciences Foundation 心筋細胞への分化能を有する細胞
WO2006088867A2 (en) * 2005-02-15 2006-08-24 Medistem Laboratories, Incorporated Method for expansion of stem cells
WO2007011088A1 (en) * 2005-07-20 2007-01-25 Seoul National University Industry Foundation Method for culturingand proliferating hematopoietic stem cells and progenitor cells using human endometrial cells
SG179432A1 (en) * 2007-03-01 2012-04-27 Mercedes A Walton Procurement, isolation and cryopreservation of endometrial/menstrual cells

Also Published As

Publication number Publication date
JP2011501960A (ja) 2011-01-20
AU2008319284A1 (en) 2009-05-07
CA2714777A1 (en) 2009-05-07
PA8802801A1 (es) 2009-06-23
NI201000077A (es) 2010-09-07
TW200936148A (en) 2009-09-01
KR20100091192A (ko) 2010-08-18
CL2008003282A1 (es) 2010-04-09
US20120208275A1 (en) 2012-08-16
BRPI0818152A2 (pt) 2014-10-14
ECSP10010189A (es) 2010-06-29
WO2009058365A1 (en) 2009-05-07
US20090191628A1 (en) 2009-07-30
EP2212418A1 (en) 2010-08-04
EP2212418A4 (en) 2010-12-08
MX2010004914A (es) 2010-08-18
CN101952416A (zh) 2011-01-19
CR11409A (es) 2010-08-13
IL205470A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
AR069156A1 (es) Metodos para co-cultivar celulas derivadas del cordon umbilical con celulas madre menstruales
UY30796A1 (es) 3-h-pirazolopiridinas y sales de éstas, composiciones farmacéuticas que las comprenden, métodos para prepararlas, y sus usos
CU24495B1 (es) Compuestos que expanden las células hematopoyéticas y método ex vivo para expandir las células hematopoyéticas
AR085507A1 (es) Animales modificados geneticamente y metodos para su obtencion
CR20110266A (es) Piridinas sustituidas con accion herbicida
AR108847A1 (es) GENERACIÓN DE CÉLULAS MADRE PLURIPOTENTES HUMANAS DERIVADAS DE CÉLULAS FUNCIONALES b CON RESPIRACIÓN MITOCONDRIAL DEPENDIENTE DE GLUCOSA Y CON RESPUESTA EN DOS FASES DE SECRECIÓN DE INSULINA
BR112013004616A2 (pt) diferenciação das células tronco embrionárias humanas
ES2721180T3 (es) Productos terapéuticos usando células adiposas y secreciones celulares
UY34111A (es) Nuevos co-cristales de agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
NI201300108A (es) Composiciones y métodos para transferencia de energía mitocondrial fe línea germinal autóloga.
GB2434157A (en) Platelets from stem cells
DOP2013000288A (es) Composiciones de lípidos algales y métodos para prepararlas y utilizarlas
BR112014027783A2 (pt) diferenciação de células-tronco embrionárias humanas em endoderma pancreático
ECSP099296A (es) Inmuno-reguladores, preparaciones y composiciones que incluyen los inmuno-reguladores, pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y métodos
CO6470821A2 (es) Pirazinilpirazoles
UY34773A (es) Ácidos indanoiloxidihidrobenzofuranilacéticos como moduladores de la actividad de gpr40, composiciones que los contienen y sus usos
CY1123467T1 (el) Θεραπευτικο εμβολιο για τη θεραπεια του παιδικου διαβητη τυπου 1, εφαρμογη του κυτταροδιαχωριστη κυτταρομετριας ροης και της μεθοδου πολλαπλασιασμου των κυτταρων treg για την παραγωγη θεραπευτικου εμβολιου για τη θεραπεια του διαβητη τυπου 1
WO2010059876A3 (en) In vitro human b lymphopoiesis culture system
CL2013000893A1 (es) Medio para cultivo de celulas de mamiferos que comprende sobrenadante de la etapa i del fraccionamiento de cohn; procedimiento de preparacion del medio; uso del medio de cultivo para cultivar celulas de mamiferos.
WO2013184193A3 (en) Cancer stem cells and methods of using the same
CL2015003402A1 (es) Células madres adultas adiposas, humanas, pluripotentes: aislamiento, caracterización e implicaciones clinicas
BR112018014519A2 (pt) carbonato de cálcio amorfo estabilizado como um suplemento para meios de cultura celular
AR120475A1 (es) Producción de células precursoras hematopoyéticas
BR112016028552A2 (pt) método para a produção de células autólogas tolerogénicos dendríticas (toldcs) com antigénios específicos e a sua utilização na preparação de um medicamento útil para o tratamento de lúpus eritematoso sistémico (les)
UY31522A1 (es) Nanoparticulas con superficie modificada

Legal Events

Date Code Title Description
FA Abandonment or withdrawal